White paper: The next step to automating clinical trials
Automating Clinical Trials
“You can say that if you meet all the needs of clinical you would meet all the needs of commercial, but you can’t say the inverse - you can’t say that if you meet all commercial needs, you’d satisfy all the regulatory requirements of a clinical setting.”
So argues Evan Hahn, VP of TSS North America, making the point that perhaps we’re guilty of offering similar solutions for both clinical and commercial distribution streams when their requirements - although they share certain elements - are ultimately different.
Download this white paper where Evan Hahn, VP TSS North America, Tobias Holmer CPO at TSS, and Cat Hall, VP of Clinical Innovation and Quality at Endpoint Clinical discuss how automating Clinical Trials and tight technical integrations are key to increasing the rate of successful outcomes of clinical trials, while also speeding up the whole clinical process.